Masimo Q4 revenue $601M (+9%); Non-GAAP EPS $1.80 (+44%); FY2025 guide sees healthcare growth 8-11%

MASIMO CORP

2024-FY EPS reported -$5.72 revenue$2,094,400,000

Q4 revenue $601M (+9% YoY); Healthcare $368M (+8%), Non-healthcare $232M (+11%).
GAAP net loss per share ($6.52) due to Sound United impairment; Non-GAAP diluted EPS $1.80 (+44%).
Full-year 2024 healthcare revenue $1,395M (+9%); Non-healthcare revenue $699M (-10%).
FY2025 guidance: Healthcare revenue $1.50B-$1.53B (8-11% constant currency), Non-GAAP EPS $5.10-$5.40.
New CEO Katie Szyman cites strong healthcare momentum and record customer contracts in 2024.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.